跳至主要内容
临床试验/NCT03490916
NCT03490916终止4 期

A Prospective, Double-blind, Randomized, Placebo-controlled Trial of Acetazolamide on Subclinical High-Altitude Pulmonary Edema Detected by Lung Ultrasonography

Vincent Kan1 个研究点 分布在 1 个国家目标入组 18 人开始时间: 2018年3月23日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
终止
发起方
入组人数
18
试验地点
1
主要终点
Pulmonary Edema Before and After Taking Acetazolamide

研究概览

简要总结

The overall goal of this study is to detect preclinical signs of HAPE by lung ultrasonography and evaluate the effectiveness of acetazolamide at decreasing pulmonary edema by using ultrasound.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years of age
  • Able to consent
  • English speaking
  • Trekking directly to Everest Base Camp

排除标准

  • Age less than 18 years
  • Non-English speaking
  • Already had a diagnosis of acute mountain sickness, high-altitude cerebral edema, or high-altitude pulmonary edema
  • Been on a high-altitude trek 2 weeks prior to this study
  • Has taken acetazolamide 1 week prior to start of trek
  • Has a sulfa allergy
  • Has any type of acute or chronic pulmonary conditions

研究组 & 干预措施

Acetazolamide normal dose

Experimental

One (1) dose of 250mg of Acetazolamide

干预措施: Acetazolamide (Drug)

Placebo

Placebo Comparator

One (1) dose of placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Pulmonary Edema Before and After Taking Acetazolamide

时间窗: 1 month

Edema measured through ultrasound exam

次要结局

  • Time to Completion of Ultrasound Exams(1 month)

研究者

发起方
Vincent Kan
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Vincent Kan

Former Fellow, Department of Emergency Medicine

University of Massachusetts, Worcester

研究点 (1)

Loading locations...

相似试验